Stanley Erck is an experienced advisor and board member in the biotechnology sector, with a career marked by significant leadership roles, including CEO at Procept and Iomai Corporation. They have been instrumental in developing numerous products through clinical trials and have successfully navigated multiple rounds of financing, including IPOs and acquisitions. Currently, they serve on the Board of Directors for MaxCyte, Inc. and Novavax, following a tenure as CEO of Iomai. Stanley earned an MBA in Economics and Finance from The University of Chicago Booth School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices